Bone Turnover in Type 2 Diabetes and Non-diabetes Controls (DiaMarv)
Condition(s):Diabetes Mellitus, Type 2; Bone FragileLast Updated:November 29, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 2; Bone FragileLast Updated:November 29, 2023Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:April 29, 2021Completed
Condition(s):Bone Fragile; Bisphosphonate-Associated Osteonecrosis; Children; Adverse EventsLast Updated:July 9, 2019Completed
Condition(s):OsteolysisLast Updated:February 7, 2019Unknown status
Condition(s):Paget’s Disease of BoneLast Updated:January 11, 2024Active, not recruiting
Condition(s):Neurofibromatosis Type 1 (NF1)Last Updated:May 25, 2022Terminated
Condition(s):Brittle Bone DiseaseLast Updated:August 16, 2016Unknown status
Condition(s):Type 1 Diabetes; Type 2 DiabetesLast Updated:September 1, 2021Completed
Condition(s):Osteoporosis; OsteoarthritisLast Updated:June 5, 2023Active, not recruiting
Condition(s):StrokeLast Updated:December 3, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.